
Nirogya Life Sciences Private Limited
About Nirogya Life Sciences Private Limited
Data last updated:
Nirogya Life Sciences Private Limited is a private limited company based in Patna, Bihar, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 17 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2017PTC034596. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Adya Pandey and Ranjana Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S/O Late Shiv Bhajan Pandey 102 Hope Arya Nandanpuri Khajpura, Patna, Bihar, India – 800014.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.02 Cr, a growth of 46% compared to the previous year. For the same year it recorded a net loss of ₹1.01 Lakh (net margin -1%) and EBITDA of ₹15.3 Lakh (EBITDA margin 14.9%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nirogya Life Sciences Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressS/O Late Shiv Bhajan Pandey 102 Hope Arya Nandanpuri Khajpura, Patna, Bihar, India – 800014
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Nirogya Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nirogya Life Sciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Nirogya Life Sciences Private Limited, buy the company report.
Financials of Nirogya Life Sciences Private Limited
FY 2025 filings availableNirogya Life Sciences Private Limited reported revenue of ₹1.02 Cr (up 46% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 46% growth in the latest year. EBITDA rose 171% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.9% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nirogya Life Sciences Private Limited, buy the company report.
Board of directors of Nirogya Life Sciences Private Limited
Nirogya Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Adya Pandey | Director | 27 Jan 2019 | 7 Years 9 Months | Current |
| Ranjana Kumari | Director | 17 May 2017 | 9 Years 6 Months | Current |
Peer comparison
Nirogya Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syannlab Solutions Private Limited | ₹1.03 Cr (FY 2025) | 4.0% | 5600Bangalore, Karnataka, India | |||
| Kaku Nana Memorial Hospital Private Limited | ₹1.03 Cr (FY 2017) | -22.0% | Beed, Maharashtra, India | |||
| Prana Integrative Medicine Institute Private Limited | ₹1.03 Cr (FY 2024) | 16.0% | New Delhi, Delhi, India | |||
| Cyl Global Solution Marketing Private Limited | ₹1.03 Cr (FY 2021) | -25.0% | Vemali, Gujarat, India | |||
| Guddi Sewa Hospital Private Limited | ₹1.03 Cr (FY 2024) | 16.0% | Lakhimpur, Uttar Pradesh, India | |||
| Nirogya Life Sciences Private Limitedthis company | ₹1.02 Cr (FY 2025) | -₹1.01 Lakh | -1% | 46.0% | Patna, Bihar, India | |
| NMD Medical Services Private Limited | ₹1.02 Cr (FY 2025) | 255.0% | New Delhi, Delhi, India | |||
| Al Amal Hospitality Private Limited | ₹1.02 Cr (FY 2025) | -20.0% | New Delhi, Delhi, India | |||
| Anaesafe Healthcare Private Limited | ₹1.02 Cr (FY 2021) | 89.0% | Bengaluru, Karnataka, India | |||
| Anjankar Eye Care Private Limited | ₹1.02 Cr (FY 2024) | 89.0% | Nagpur, Maharashtra, India | |||
| Credo Medical Center Private Limited | ₹1.02 Cr (FY 2024) | 9.0% | Srimangala Virajpet, Karnataka, India |
To see the full peer comparison of Nirogya Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nirogya Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nirogya Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nirogya Life Sciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Nirogya Life Sciences Private Limited, buy the company report.
Recent activity
Nirogya Life Sciences Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Adya Pandey was appointed as Director on 27 Jan 2019.
Frequently asked questions
Nirogya Life Sciences is an active private limited company based in Patna, Bihar, India. The company works in other services, within the business services industry. It was incorporated on 17 May 2017 (9+ years old) and is registered under CIN U74999BR2017PTC034596.
Nirogya Life Sciences has 2 current directors:
- Adya Pandey - Director
- Ranjana Kumari - Director
The latest financial statements of Nirogya Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
No. Nirogya Life Sciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Nirogya Life Sciences is U74999BR2017PTC034596. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nirogya Life Sciences was incorporated on 17 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Nirogya Life Sciences by revenue are Syannlab Solutions Private Limited, Kaku Nana Memorial Hospital Private Limited, Prana Integrative Medicine Institute Private Limited, Cyl Global Solution Marketing Private Limited, Guddi Sewa Hospital Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Adya Pandey was appointed as Director on 27 Jan 2019. Gupteshwar Nath Pandey ceased to be Director on 27 Jan 2019. Ranjana Kumari was appointed as Director on 17 May 2017.
The registered office of Nirogya Life Sciences is at SO Late Shiv Bhajan Pandey 102 Hope Arya Nandanpuri Khajpura, Patna, Bihar, India – 800014.
Nirogya Life Sciences operates in the business services industry, in the other services segment.
The compliance status of Nirogya Life Sciences is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.

